Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Warren RJ and Fotherby K Radioimmunoassay of synthetic progestogens, norethisterone and norgestrel. 1974 J. Endocrinol. pmid:4415456
Easterling WE et al. Serum testosterone levels in the polycystic ovary syndrome. Effect of an estrogen-progestin on protein binding of testosterone. 1974 Am. J. Obstet. Gynecol. pmid:4415747
Gardner LI The susceptibility of the fetus and child to chemical pollutants. Special susceptibility of the host to chemical agents: endocrinologic considerations. 1974 Pediatrics pmid:4416533
Freudenthal RI and Amerson E Effect of synthetic estrogens and estrogen-progestin combinations on the hepatic microsomal enzyme system. 1974 Biochem. Pharmacol. pmid:4418540
Tüttenberg KH et al. Effects of synthetic progestagens on drug metabolism in rat liver microsomes. 1974 Biochem. Pharmacol. pmid:4418729
Altschuler SL and Valenteen JW Amenorrhea following rifampin administration during oral contraceptive use. 1974 Obstet Gynecol pmid:4423170
Cole ER Effect of steroids, including progestin and estrogen components of oral contraceptive drugs, on the esterase activity of thrombin. 1974 Thromb. Res. pmid:4428464
Mills TM et al. The metabolic clearance rate and urinary excretion of oral contraceptive drugs. I. Norethindrone. 1974 Am. J. Obstet. Gynecol. pmid:4429084
Mills TM et al. The metabolic clearance rate and urinary excretion of oral contraceptive drugs. II. Mestranol. 1974 Am. J. Obstet. Gynecol. pmid:4429085
McPherson JC et al. Effects of various progestational preparations on gonadotropin secretion in ovariectomized immature female rats. 1974 Fertil. Steril. pmid:4430386
Badr FM and Badr RS Studies on the mutagenic effect of contraceptive drugs. I. Induction of dominant lethal mutations in female mice. 1974 Mutat. Res. pmid:4431426
Röhrborn G and Hansmann I Oral contraceptives and chromosome segregation in oocytes of mice. 1974 Mutat. Res. pmid:4431427
Pontuch A [Treatment of climacteric disorders (author's transl)]. 1974 Cesk Gynekol pmid:4434524
Knejzlíková I et al. [Prevention of dysfunctional climacteric bleeding by Norbiogest (author's transl)]. 1974 Cesk Gynekol pmid:4434527
Altman R et al. The effect in vitro of the steroidal component of oral contraceptives on platelet aggregation. 1974 Experientia pmid:4435137
Bergsjo P et al. Tubal pregnancies in women using progestagen-only contraception. 1974 Acta Obstet Gynecol Scand pmid:4440467
Chai LS et al. Ultrastructural study of hepatic effects of a contraceptive steroid in baboon. 1974 Contraception pmid:4442267
Nygren KG et al. The contraceptive efficacy of 10mg or 25mg of norethindrone given orally on day 15-22 of the human menstrual cycle. 1974 Contraception pmid:4442274
Nygren KG and Johansson ED Recurrence of ovulation after daily, oral administration of 10 mg of norethindrone on day 15-22 and on day 8-15 of the human menstrual cycle. 1974 Contraception pmid:4442275
Nygren KG et al. Radioimmunoassay of norethindrone: peripheral plasma levels after oral administration to humans and rhesus monkeys. 1974 Contraception pmid:4442276
Srinivasan S et al. The alteration of surface charge characteristics of the vascular system by oral contraceptive steroids. 1974 Contraception pmid:4442278
Medhat IA et al. A study of the effect of an oral contraceptive on blood coagulation factors, platelets and fibrinolytic activity. 1974 Contraception pmid:4442281
[Withdrawal of "high estrogenic" contraceptive pills]. 1974 Ugeskr. Laeg. pmid:4446083
Tejuja S et al. A preliminary report on the contraceptive use of subdermal implants containing norethindrone. 1974 Contraception pmid:4448056
Tremblay RR and Dube JY Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. 1974 Contraception pmid:4448070
Friedman S et al. Acute opthalmologic complications during the use of oral contraceptives. 1974 Contraception pmid:4452242
Freudenthal RI et al. The effectof norethynodrel, norethindrone and ethynodiol diacetate on hepatic microsomal drug metabolism. 1974 Pharmacol Res Commun pmid:4456419
Con-fer: contraception plus iron. 1974 Drug Ther Bull pmid:4459054
Charnot Y et al. [Preliminary study of the influence of the oral synthetic oestrogen-gestogens on the rate of calcium, magnesium and silicon in some tissues fo the female rats]. 1974 Ann. Endocrinol. (Paris) pmid:4464800
Reel JR et al. Competitive progesterone antagonists: receptor binding and biologic activity of testosterone and 19-nortestosterone derivatives. 1979 Fertil. Steril. pmid:446780
Laufe LE et al. Volume and copper concentration of menstrual discharge from women employing copper-7 and other types of contraceptives. 1974 Adv Plan Parent pmid:4468904
Prole JH The control of oestrus in racing Greyhound bitches using norethisterone acetate. 1974 J Small Anim Pract pmid:4476035
Prole JH The effect of the use of norethisterone acetate to control oestrus in Greyhound bitches on subsequent racing performance and fertility. 1974 J Small Anim Pract pmid:4476036
Ishihara S et al. [Proceedings: Follicle hormone activity of norethindrone in the hypothalamic nucleus]. 1974 Nihon Naibunpi Gakkai Zasshi pmid:4476526
Arora P Silastic implant: a new method for birth control. 1973 Nurs J India pmid:4493439
Ng KH and Lee KH Inhibition of postpartum lactation with single-dose drugs. 1972 Aust N Z J Obstet Gynaecol pmid:4502478
Pearlman BA An oral contraceptive drug and gingival enlargement; the relationship between local and systemic factors. 1974 J. Clin. Periodontol. pmid:4532116
Biggs JS Hair growth in a patient with hirsutism: poor response to ovarian suppression. 1973 Aust N Z J Obstet Gynaecol pmid:4532547
Cook CE et al. Norethindrone plasma levels in human subjects. 1974 Life Sci. pmid:4549998
Zacherle BJ and Richardson JA Irreversible renal failure secondary to hypertension induced by oral contraceptives. 1972 Ann. Intern. Med. pmid:4559540
Leklem JE et al. Effect of oral contraceptives on urinary metabolite excretions after administration of L-tryptophan or L-kynurenine sulfate. 1973 Metab. Clin. Exp. pmid:4587003
Stoll BA Hormonal therapy of gynecologic malignancy. 1973 Clin Obstet Gynecol pmid:4593949
Kucera J [Congenital defects due to drugs]. 1973 Cesk Pediatr pmid:4594858
Segal SJ New approaches to contraception. 1974 Clin Obstet Gynecol pmid:4596675
Mishell DR Current status of contraceptive steroids and the intrauterine device. 1974 Clin Obstet Gynecol pmid:4596680
Dorfman RI Hormonal contraception. 1974 Life Sci. pmid:4597495
Semmer JR and Diddle AW Oral contraceptive medication and glucose metabolism: long-term treatment. 1974 South. Med. J. pmid:4597914
Vandenberg G et al. Effects of exogenous estrogen and progestin on pituitary responsiveness to synthetic luteinizing hormone-releasing factor. 1974 J. Clin. Invest. pmid:4598115
Cohen T and Cooney DP Cyclic thrombocytopenia. Case report and review of literature. 1974 Scand J Haematol pmid:4598703
Ross GT Gonadotropins and preantral follicular maturation in women. 1974 Fertil. Steril. pmid:4599101
Bagdade JD Therapy of the hyperlipoproteinemias. 1972 Acta Diabetol Lat pmid:4605376
Udry JR et al. Effect of contraceptive pills on sexual activity in the luteal phase of the human menstrual cycle. 1973 Arch Sex Behav pmid:4618468
Chandra RK Serum levels of IgG and -macroglobulin and incidence of cryofibrinogenaemia in women taking oral contraceptives. 1972 J. Reprod. Fertil. pmid:4622500
Norrby A et al. The influence of a combined oral contraceptive on the absorption of iron. 1972 Scand J Haematol pmid:4626808
Starker W and Fricke HJ [Glucose assimilation under high-dose norethisterone-acetate therapy in adenocarcinoma of the corpus uteri]. 1979 Zentralbl Gynakol pmid:463410
Wilensky RJ and Hubbard TB Thrombosis of the digital vessels secondary to oral contraceptives. 1972 Am. J. Obstet. Gynecol. pmid:4635186
Tenhaeff D et al. [Contraception with two low-dosage mestranol-norethisterone combinations]. 1972 Fortschr. Med. pmid:4641330
Cochrane P and Weatherall DJ The variation of neutrophil alkaline phosphatase during the menstrual cycle. 1972 J Obstet Gynaecol Br Commonw pmid:4642375
Larsson-Cohn U et al. Concentration of antithrombin 3 during combined and progestogen-only oral contraceptive treatment. 1972 Acta Obstet Gynecol Scand pmid:4642717
Starup J Amenorrhoea following oral contraception. 1972 Acta Obstet Gynecol Scand pmid:4642722
Mishell DR et al. Serum estradiol in women ingesting combination oral contraceptive steroids. 1972 Am. J. Obstet. Gynecol. pmid:4645131
[Can the mini-pills be taken cyclically?]. 1972 Tidsskr. Nor. Laegeforen. pmid:4649638
el-Mahgoub S and Karim M The long-term use of injectable norethisterone enanthate as a contraceptive. 1972 Contraception pmid:4650643
Boris A et al. The effects of some progestational steroids on pubertal ovulation in the rat. 1972 Contraception pmid:4650647
Nygren KG et al. Postovulatory contraception in women with large doses of norethindrone. 1972 Contraception pmid:4650660
el-Mahgoub S and Ammar R Ovarian changes during progestogen amenorrhoea. 1972 J Obstet Gynaecol Br Commonw pmid:4651295
Anglade JP [Norethisterone acetate and endometriosis. Clinical study apropos of 10 cases]. 1972 Sep-Oct Therapie pmid:4651404
Moghissi KS Morphologic changes in the ovaries of women treated with continuous microdose progestogens. 1972 Fertil. Steril. pmid:4651625
Preston SN A report of a collaborative dose-response clinical study using decreasing doses of combination oral contraceptives. 1972 Contraception pmid:4659582
van Kordelaar JB et al. Interaction of contraceptive progestins and related compounds with the oestrogen receptor. Part I: Effect on (3H)oestradiol distribution pattern in the ovariectomized rat. 1975 Acta Endocrinol. pmid:46680
van Kordelaar JM et al. Interaction of contraceptive progestins and related compounds with the oestrogen receptor. Part II: Effect on (3H)oestradiol binding to the rat uterine receptor in vitro. 1975 Acta Endocrinol. pmid:46681
Nygren KG and Johansson ED The effect of norethindrone and some other synthetic gestagens upon the peripheral plasma levels of progesterone and estradiol during early, human pregnancy. 1975 Acta Obstet Gynecol Scand pmid:46683
Lawson JP and Bradshaw FR Experience with norethisterone 0.35 mg. as an oral contraceptive--a preliminary report. 1972 Curr Med Res Opin pmid:4668861
Burton FG et al. Low-level, progestogen-releasing vaginal contraceptive devices. 1979 Contraception pmid:467057
Anglade JP [Clinical study of norethisterone acetate in functional metrorrhagia and in pre- and permenstrual painful syndromes]. 1972 Sep-Oct Therapie pmid:4675625
Larsson-Cohn U et al. Effects of continuous daily administration of 0.1 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone and total oestrogens. 1972 Acta Endocrinol. pmid:4678199
Rifkin I et al. Amenorrhea following use of oral contraceptives. 1972 Am. J. Obstet. Gynecol. pmid:4678381
Avoidance of dual publication. Statement by the Council of Biology Editors. 1973 Am. J. Obstet. Gynecol. pmid:4681830
Davidson MB and Holzman GB Role of growth hormone in the alteration of carbohydrate metabolism induced by oral contraceptive agents. 1973 J. Clin. Endocrinol. Metab. pmid:4683182
Rose DP and Toseland PA Urinary excretion of quinolinic acid and other tryptophan metabolites after deoxypyridoxine or oral contraceptive administration. 1973 Metab. Clin. Exp. pmid:4683526
Baker BL et al. Direct action of synthetic progestins on the hypophysis. 1973 Endocrinology pmid:4686326
Freudenthal RI et al. Metabolism and distribution of norethynodrel in pregnant and nonpregnant mice. 1973 Toxicol. Appl. Pharmacol. pmid:4686779
Banerjee RC et al. Effects of norethindrone (17-ethynyl-17 -hydroxy-4-estren-3-one) and norgestrel (dl-13 -ethyl-17-ethynyl-17 -hydroxy-4-gonen-3-one) on the tissue distribution of 3 H-estradiol-17 in ovariectomized rats. 1973 Steroids pmid:4687305
Lunell NO et al. The effects of an oral combined contraceptive on plasma levels of glucose, free fatty acids, glycerol, D- hydroxybutyrate and triglycerides. 1973 Acta Obstet Gynecol Scand pmid:4688539
Johnson GK et al. Small intestinal disease, folate deficiency anemia, and oral contraceptive agents. 1973 Am J Dig Dis pmid:4688570
Wardekar AS et al. Myocardial infarction and oral contraceptives. 1973 South. Med. J. pmid:4691020
Hollander A and Grots IA Mucha-Habermann disease following estrogen-progesterone therapy. 1973 Arch Dermatol pmid:4692137
Stray-Pedersen B [The minipill]. 1973 Tidsskr. Nor. Laegeforen. pmid:4693979
Jones RC and Edgren RA The effects of various steroids on the vaginal histology in the rat. 1973 Fertil. Steril. pmid:4694503
Phillips N and Duffy T One-hour glucose tolerance in relation to the use of contraceptive drugs. 1973 Am. J. Obstet. Gynecol. pmid:4697175
Grussendorf EI and Gahlen W [Therapeutic trial in myxedematous lichen using Primolut-Nor]. 1973 Hautarzt pmid:4697323
Wallace ME et al. Studies in mice on the mutagenicity of two contraceptive drugs. 1979 J. Med. Genet. pmid:469899
Jaffe P et al. Letter: Incidence of congenital limb-reduction deformities. 1975 Lancet pmid:47000
Feldmann HU et al. [Contraception using daily micro-dosage of norethisterone]. 1973 Fortschr. Med. pmid:4702395
Maleki M and Lange RL Coronary thrombosis in young women on oral contraceptives: report of two cases and review of the literature. 1973 Am. Heart J. pmid:4702663
Corriere JN Pathologic changes in the human urinary tract due to anovulatory drug administration. 1973 J Surg Oncol pmid:4703842
Galletti F and Gardi R Effect of ovarian hormones and synthetic progestins on vaginal sialic acid in the rat. 1973 J. Endocrinol. pmid:4706599
Langlands AO and Martin WM Letter: Jaundice associated with norethisterone-acetate treatment of breast cancer. 1975 Lancet pmid:47070
Garmendia F et al. Serum LH concentration in women under contraceptive treatment with estrogen-free progestagens. 1973 Horm. Metab. Res. pmid:4707699
Spellacy WN et al. Metabolic studies in women taking norethindrone for 6 months' time (measurements of blood glucose, insulin, and triglyceride concentrations). 1973 Fertil. Steril. pmid:4710007